TECX
Tectonic Therapeutic, Inc.
NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY
$27.97
+3.32% today
Updated 2026-04-30
Market cap
$512.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.05
Dividend yield
—
52W range
$14 – $36
Volume
0.3M
Tectonic Therapeutic, Inc. (TECX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-37.80%
ROA
-25.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | — | $-4.66M | — | — | — |
| 2017 | — | $-18.65M | — | — | — |
| 2018 | — | $-46.36M | — | — | — |
| 2019 | — | $-72.97M | — | — | — |
| 2020 | — | $-119.71M | — | — | — |
| 2021 | $0.00 | $-8.93M | — | — | — |
| 2022 | $0.00 | $-32.18M | — | — | — |
| 2023 | $0.00 | $-42.82M | — | — | — |
| 2024 | $0.00 | $-57.98M | — | — | — |
| 2025 | $0.00 | $-74.15M | — | — | — |